Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Feb 7, 2025 · 10-Q · 38 days after period end · 0001740797-25-000014
| Metric | Q3 2025 | Q3 2024 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$452.30K | -$1.01M | -$417.16K | -$10.17K |
| EPS Diluted | — | — | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Feb 7, 2025 · 38 d after period end
